E74.02
Pompe disease
Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 11 never code together
E74code
Excludes1
- diabetes mellitus (E08-E13)E08-E13
- hypoglycemia NOS (E16.2)E16.2
- increased secretion of glucagon (E16.3)E16.3
- mucopolysaccharidosis (E76.0-E76.3)E76.0-E76.3
E70-E88block
E00-E89chapter
Excludes1
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74
Excludes1 — never code together. The excluded condition and this one are mutually exclusive.
Excludes2 — not included here, but the patient may have both. Code both when documented.
Instructional notes 3
E74.02code
Inclusion terms
- Cardiac glycogenosis
- Type II glycogen storage disease
E00-E89chapter
Notes
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here 9
- Infiltrate, infiltration
- Glycogenosis (diffuse) (generalized) — see also Disease, glycogen storage
- cardiac E74.02
- Cardiomyopathy (familial) (idiopathic) I42.9
- Myocardiopathy (congestive) (constrictive) (familial) (hypertrophic nonobstructive) (idiopathic) (infiltrative) (obstructive) (primary) (restrictive) (sporadic) I42.9
- Cardiomegalia glycogenica diffusa E74.02
- Cardiomegaly — see also Hypertrophy, cardiac
- glycogen E74.02
- Deficiency, deficient
- lysosomal alpha-1, 4 glucosidase E74.02
- Disease, diseased — see also Syndrome
- Pompe's disease (glycogen storage) E74.02
Alongside this code 6 same parent — E74.0
Additional references
AHA Coding Clinic® Licence required
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.